CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- 4 Shares withheld for taxes President and COO gave up 4,361 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,645 shares (to pay taxes)
- 4 Open-market sale President and COO sold 2,146 shares at $17.89 ($38,382)
- 4 Shares withheld for taxes CFO and Treasurer gave up 2,087 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 1,688 shares at $17.89 ($30,191)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,392 shares (to pay taxes)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Open-market sale President and COO sold 1,201 shares at $17.60 ($21,138)
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,168 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 945 shares at $17.60 ($16,632)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Shares withheld for taxes Chief Executive Officer gave up 2,949 shares (to pay taxes)
- 8-K Event Other events
- 4 Grant or award Director acquired 5,558 shares (grant or award)
- 4 Grant or award Director acquired 11,117 shares (grant or award)
- 4 Grant or award Director acquired 11,117 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
Page 2 of 34 · 670 filings